Tarsus Pharmaceuticals, Inc. — Institutional Ownership
Which tracked institutions hold TARS, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
26
Funds holding
$925540823
Total value held
Buying
19 added/new · 7 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $249215733 | 3552612 | -237945 | -6.28% |
| 2 | Janus Henderson Group Plc | $157222823 | 2240963 | — | NEW BUY |
| 3 | Morgan Stanley | $136390741 | 1944272 | -96470 | -4.73% |
| 4 | Bank Of America Corp /De/ | $83785547 | 1194377 | +436271 | +57.55% |
| 5 | Invesco Ltd. | $82891790 | 1012357 | +75351 | +8.04% |
| 6 | State Street Corp | $68621572 | 978212 | +49153 | +5.29% |
| 7 | Toronto Dominion Bank | $35794248 | 510253 | — | NEW BUY |
| 8 | Goldman Sachs Group Inc | $30839764 | 439626 | +60922 | +16.09% |
| 9 | Northern Trust Corp | $24759934 | 352957 | +10471 | +3.06% |
| 10 | Franklin Resources Inc | $23407371 | 333676 | -3340 | -0.99% |
| 11 | Wells Fargo & Company/Mn | $9748469 | 119058 | +20307 | +20.56% |
| 12 | Bank Of New York Mellon Corp | $7490791 | 106782 | -978 | -0.91% |
| 13 | Citigroup Inc | $4255386 | 51971 | +11380 | +28.04% |
| 14 | Raymond James Financial Inc | $2440096 | 34784 | -865 | -2.43% |
| 15 | Nomura Holdings Inc | $2433153 | 34685 | — | NEW BUY |
| 16 | Sei Investments Co | $2179739 | 31075 | — | NEW BUY |
| 17 | Barclays Plc | $1964481 | 28004 | — | NEW BUY |
| 18 | Ameriprise Financial Inc | $599853 | 8551 | -52 | -0.60% |
| 19 | Prudential Financial Inc | $436684 | 6225 | +3615 | +138.51% |
| 20 | Fifth Third Bancorp | $345353 | 4923 | — | NEW BUY |
| 21 | M&T Bank Corp | $255400 | 3115 | -580 | -15.70% |
| 22 | Royal Bank Of Canada | $208000 | 2960 | — | NEW BUY |
| 23 | Principal Financial Group Inc | $200278 | 2855 | — | NEW BUY |
| 24 | Pnc Financial Services Group, Inc. | $49807 | 710 | +558 | +367.11% |
| 25 | Us Bancorp \De\ | $3788 | 54 | +36 | +200.00% |
| 26 | Amalgamated Financial Corp. | $22 | 1306 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.